Prasugrel 10 mg

DRUG3 trials

Sponsors

Eli Lilly and Company, Lene Holmvang, University of Florida

Conditions

Acute Coronary SyndromeAcute Coronary SyndromesCoronary ArteriosclerosisCoronary Artery DiseasePercutaneous Coronary Intervention

Phase 2

Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event

CompletedNCT00356135

Eli Lilly and CompanyAcute Coronary Syndrome, Coronary Arteriosclerosis

Start: 2006-07-31End: 2008-12-31Updated: 2010-11-03

Phase 4

Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI

CompletedNCT01135667

Lene HolmvangAcute Coronary Syndromes, Coronary Artery Disease, Percutaneous Coronary Intervention

Start: 2010-09-30End: 2012-08-31Updated: 2012-10-04

Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors

RecruitingNCT06691191

University of FloridaCoronary Artery Disease

Start: 2025-01-08End: 2026-12-31Target: 48Updated: 2026-02-05

Related Papers

Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) study.

2010-09-01123 citations